Asit Parikh, Director at Phathom Pharmaceuticals, Inc. (PHAT), bought 12,500 shares at $8.00 ($100K) on 2022-05-12, disclosed to the SEC on 2022-05-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| PHAT | BUY | 2024-12-16 | $162K | — | Filing → |
| PHAT | BUY | 2023-11-08 | $59K | — | Filing → |
| PHAT | BUY | 2023-04-11 | $8K | — | Filing → |